Advertisement
Journal Home
Search for

Volume 41, Issue 1, Pages 129-133 (January 2010)


View previous. 22 of 30 View next.

Follicular dendritic cell sarcoma with immature T-cell proliferation

Wook Youn Kim, MDa, Haeryoung Kim, MD, PhDbCorresponding Author Informationemail address, Yoon Kyung Jeon, MD, PhDaCorresponding Author Informationemail address, Chul-Woo Kim, MD, PhDa

Received 29 January 2009; received in revised form 22 April 2009; accepted 22 May 2009. published online 09 September 2009.

Summary 

Follicular dendritic cell sarcoma is characterized by proliferation of spindled to ovoid cells reminiscent of follicular dendritic cells. However, the association of follicular dendritic cell sarcoma with a dense infiltration of immature T cells has not hitherto been reported. We report an unusual case of follicular dendritic cell sarcoma of the mesentery with immature T-cell proliferation in a 68-year-old man. The infiltrating immature T cells demonstrated expression of CD3, CD1a, TdT, and coexpression of CD4 and CD8 by immunohistochemistry. In addition, the patient was subsequently diagnosed with myasthenia gravis and paraneoplastic pemphigus and died of distant metastasis within 2 years after initial diagnosis of follicular dendritic cell sarcoma. The aggressive clinical course of this case contrasts with the indolent course of follicular dendritic cell sarcomas, and thus, the prognostic implications of follicular dendritic cell sarcoma with immature T-cell proliferation require clarification. The complication of myasthenia gravis and paraneoplastic pemphigus may suggest that immature T-cell proliferation has an autoimmunity-related systemic influence.

a Department of Pathology and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea

b Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Kyeonggi-do 463-707, Korea

Corresponding Author InformationCorresponding authors. Yoon Kyung Jeon, is to be contacted at Department of Pathology, Seoul National University Hospital, Jongro-gu, Seoul 110-799, Korea. Haeryoung Kim, is to be contacted at Department of Pathology, Seoul National University Bundang Hospital, Bundang-gu, Seongnam 463-707, Korea.

 This work was supported by grants from the Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine.

PII: S0046-8177(09)00233-0

doi:10.1016/j.humpath.2009.05.014


View previous. 22 of 30 View next.

Advertisement